Greg R.J. Thatcher , Ph.D.
Professor & Asst. Head, Medicinal Chemistry & Pharmacognosy

Disease/Therapeutics, Cognition/Learning
Approaches to neurodegenerative and affective disorders through modulating estrogenic and serotonergic pathways in the CNS and in particular NO/cGMP signaling.  Design and synthesis of novel small molecules that modulate these pathways is complemented by cell based assays and study in animal behavioral models.  One molecule has entered clinical trials for Alzheimer's disease.

Selected references